Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB08842_nanopub.RAhwmEQXkKPT7ViYzoF34LzZzZEkxr1-imLsibbX_fXyI#assertion>. }
Showing items 1 to 17 of
17
with 100 items per page.
- drugbank:DB08842 type drugbank_vocabulary:Drug assertion.
- drugbank:DB08842 label "Acetylcarnitine [drugbank:DB08842]" assertion.
- drugbank:DB08842 seeAlso DB08842 assertion.
- drugbank:DB08842 seeAlso supplements.htm assertion.
- drugbank:DB08842 identifier "drugbank:DB08842" assertion.
- drugbank:DB08842 description "Acetylcarnitine is an investigational drug in the United states, Italy, United Kingdom, China, Israel, and Norway, and it is approved in Italy, Portugal, Argentina, Chile, Philippines, Australia, and India. Acetylcarnitine can be synthesized, but it is also naturally found in adequate amounts in healthy humans. In human plasma and tissues, acetylcarnitine is the most predominant acylated ester of carnitine, which is an amino acid derivative that is made in the kidney, liver, and brain from lysine and methionine. The main role of acetylcarnitine is to help transport fatty acids into the mitochondrial matrix where fatty acid metabolism occurs." assertion.
- drugbank:DB08842 title "Acetylcarnitine" assertion.
- drugbank:DB08842 bio2rdf_vocabulary:identifier "DB08842" assertion.
- drugbank:DB08842 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB08842 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB08842" assertion.
- drugbank:DB08842 bio2rdf_vocabulary:x-identifiers.org DB08842 assertion.
- drugbank:DB08842 drugbank_vocabulary:drugbank-id "DB08842" assertion.
- drugbank:DB08842 drugbank_vocabulary:x-cas cas:3040-38-8 assertion.
- drugbank:DB08842 drugbank_vocabulary:x-atc atc:N06BX12 assertion.
- drugbank:DB08842 drugbank_vocabulary:x-chebi chebi:57589 assertion.
- drugbank:DB08842 drugbank_vocabulary:x-kegg kegg:C02571 assertion.
- drugbank:DB08842 drugbank_vocabulary:x-wikipedia wikipedia:Acetylcarnitine assertion.